| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/14/2004 | WO2004087045A2 Devices, methods, and compositions to prevent restenosis |
| 10/14/2004 | WO2004087043A2 Stable ophthalmic formulation containing an antibiotic and a corticosteroid |
| 10/14/2004 | WO2004087040A2 Uses for l-tetrahydropalmatine |
| 10/14/2004 | WO2004087038A1 Kit for pharmaceutical use |
| 10/14/2004 | WO2004086880A1 Sodium chloride-containing foods and drinks |
| 10/14/2004 | WO2004086865A1 Compounds, compositions and methods |
| 10/14/2004 | WO2004082658A1 Controlled release system containing saccharose acetate isobutyrate |
| 10/14/2004 | WO2004078116A3 P38 inhibitors and methods of use thereof |
| 10/14/2004 | WO2004076414A3 Novel compounds |
| 10/14/2004 | WO2004075811A3 Subcutaneously-administered ganglioside-based vaccine compositions |
| 10/14/2004 | WO2004073583A3 Use of antimuscarinic drugs for preventing the onset of epilepsy |
| 10/14/2004 | WO2004072253A9 Human excitatory amino acid transporter-2 gene promoter and uses thereof |
| 10/14/2004 | WO2004071416A3 Novel inhibitors of formation of advanced glycation endproducts (ages) |
| 10/14/2004 | WO2004071401A3 Hydroxamic acid derivatives as histone deacetylase inhibitors (hdca) |
| 10/14/2004 | WO2004071397A3 Combination therapy of zd6474 with 5-fu or/and cpt-11 |
| 10/14/2004 | WO2004071152A3 Use of s-10 hydroxy-10, 11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders |
| 10/14/2004 | WO2004067550A3 Novel use of mifepristone and derivatives thereof as hedgehog protein signalling pathway modulators and applications of same |
| 10/14/2004 | WO2004067508A3 Use of photodynamic therapy therapeutic agents entrapped in ceramic nanoparticles |
| 10/14/2004 | WO2004062552A3 Pharmaceutical composition containing a nsaid and a benzimidazole derivative |
| 10/14/2004 | WO2004060379A3 Pharmaceutical compositions comprising an antibacterial agent nd antifungal agent and a nitroimidazole for the treatment and prevention of genitourinary infections and their extragenital complications |
| 10/14/2004 | WO2004058252A3 Anti-cancer agents comprising alkb inhibitors and alkylating agents |
| 10/14/2004 | WO2004052905A3 Antiviral nucleoside derivatives |
| 10/14/2004 | WO2004052346A8 Pharmaceutical compositions containing indistinguishable drug components |
| 10/14/2004 | WO2004052315A3 Tyrosine kinase inhibitors |
| 10/14/2004 | WO2004043367A3 Fused heterocyclic compounds and use thereof |
| 10/14/2004 | WO2004043360A3 Methods of using vitamin d compounds in the treatment of myelodysplastic syndromes |
| 10/14/2004 | WO2004041245B1 Pharmaceutical solutions comprising a modafinil compound and their use for the manufacture of a medicament for treating different diseases |
| 10/14/2004 | WO2004041152A3 Antigenic targets of autoimmune sensorineural hearing loss (aisnhl) and development of tests fro diagnosis and management of aisnhl |
| 10/14/2004 | WO2004039311A3 Human vps4a and vps4b functions in viral budding |
| 10/14/2004 | WO2004037853A3 Quinolones with anti-hiv activity |
| 10/14/2004 | WO2004032840A3 Compounds, compositions, and methods |
| 10/14/2004 | WO2004032827A3 Hepatitis c virus inhibitors |
| 10/14/2004 | WO2004031233A3 Novel chemokine-like polypeptides |
| 10/14/2004 | WO2004026118A3 Administration of free radical scavengers to prevent or treat ischemia-reperfusion injuries |
| 10/14/2004 | WO2004024939A3 Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof |
| 10/14/2004 | WO2004024063A3 Compositions and methods for the diagnosis and treatment of tumor |
| 10/14/2004 | WO2004021010A3 Method of diagnosing colon and gastric cancers |
| 10/14/2004 | WO2004019866B1 Compositions and methods for treating cardiovascular disease |
| 10/14/2004 | WO2004017916A3 Cardiovascular therapy composition including transfer factor and therapeutic methods including use of the composition |
| 10/14/2004 | WO2004015130A3 Modulators of rabggt and methods of use thereof |
| 10/14/2004 | WO2004005256A3 Substituted 4-phenyl-piperidin-amides as tachykinin antagonists and serotonin reptake inhibitors |
| 10/14/2004 | WO2004004655A3 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 10/14/2004 | WO2004000785A3 Phenyloxyalkanonic acid derivatives as hppar activators |
| 10/14/2004 | WO2004000781A3 Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
| 10/14/2004 | WO2004000762A3 Propionic acid derivatives and their use as hppars activators |
| 10/14/2004 | WO2003104475A3 Atm related kinase atx, nucleic acids encoding same and methods of use |
| 10/14/2004 | WO2003104282A3 Glycoprotein vi - fc fusion protein for treating vascular disorders |
| 10/14/2004 | WO2003079974A3 Integrin ligand |
| 10/14/2004 | WO2003075945A3 Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis |
| 10/14/2004 | WO2003007936A8 Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
| 10/14/2004 | US20040205835 Jak kinases and regulation of cytokine signal transduction |
| 10/14/2004 | US20040204862 Computer-based model for identification and characterization for non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors |
| 10/14/2004 | US20040204673 Modular infusion device and method |
| 10/14/2004 | US20040204617 Solvent extraction to remove free radical of p-benzoquinone (p-benzosemiquinone) from cigarette; purification, crystallization and quantitative analysis |
| 10/14/2004 | US20040204599 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions |
| 10/14/2004 | US20040204596 preventing or treating degradation of collagen, degradation of collagen by bacterial collagenases during a bacterial infection, regeneration of skin and ligaments, tumoral invasion and degenerative diseases having fibrinoid degeneration of collagen |
| 10/14/2004 | US20040204594 S-(+)-4-Methoxy-6-phenethyl-5,6-dihydro-pyran-2-one; plant extracts for nutraceutical foods, topical ointments |
| 10/14/2004 | US20040204591 Reacting an amide compound containing hydroxy and a carboxyl group and having benzene ring, with a halogenated alkyl aminocarbonyl-pyrrolidine with 2-fluoro groups substituted at the ring carbon, by amindation of amine and carboxyl group |
| 10/14/2004 | US20040204590 Ep4 receptor agonist, compositions and methods thereof |
| 10/14/2004 | US20040204588 aryl hydrocarbon; oxidation of 4,5-dihydro-1,3-azoles to fully unsaturated ring; heterocyclic ketones |
| 10/14/2004 | US20040204586 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 10/14/2004 | US20040204582 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 10/14/2004 | US20040204578 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 10/14/2004 | US20040204501 Substituted tropolone compounds, oral care compositions containing the same and methods of using the same |
| 10/14/2004 | US20040204499 Preparation for breast duct fluid collection |
| 10/14/2004 | US20040204498 Pyrimidine carboxamides; 5-hydroxy-2-(2-(1,1-Dioxo-6-[1,2]thiazinan-2-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamides; AIDS; AIDS related complex |
| 10/14/2004 | US20040204497 Having properties include positive blood sugar regulation, increased thermogenesis and fat loss, increased anticatabolism/anabolism, decreased appetite, improved mental focus and psychological outlook and increased energy production and anti-fatigue actions |
| 10/14/2004 | US20040204495 Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment of prevention of pain and/or headache disorders |
| 10/14/2004 | US20040204494 Having anticancer, anti-proliferous and anti-inflammatory effects and immunosuppressive and muscle relaxing functions |
| 10/14/2004 | US20040204493 Carbonic anhydrase inhibitors as drugs to eradicate Helicobacter pylori in the mammalian, including human, stomach |
| 10/14/2004 | US20040204492 Topical composition and method for treating seborrheic dermatitis |
| 10/14/2004 | US20040204491 Use of fatty acid derivatives (FADs) and in particular of 13,14-diyhdro-15-keto-prostaglandins for antagonizing the effect of endothelin-1 on ocular blood vessels |
| 10/14/2004 | US20040204489 Method of treating a swollen gland curing cancer |
| 10/14/2004 | US20040204487 Novel medicinal product |
| 10/14/2004 | US20040204486 Anandamide and structurally related lipids as vanilloid receptor modulators |
| 10/14/2004 | US20040204484 Therapeutic mixture useful in inhibiting lesion formation after vascular injury |
| 10/14/2004 | US20040204482 provides a defined blood concentration profile having no rapid initial rise in blood plasma concentration of the good soluble active substance when administered; (R)-3-N,N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide; nervous system, gastrointestinal, heart disorders, Alzheimer's |
| 10/14/2004 | US20040204481 Activation of natural killer cells by adenosine A3 receptor agonists |
| 10/14/2004 | US20040204480 Anti-cancer combinations |
| 10/14/2004 | US20040204479 Injectable composition |
| 10/14/2004 | US20040204478 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 10/14/2004 | US20040204477 For use as antiproliferative agents |
| 10/14/2004 | US20040204476 Oxopyrrolidine compounds, preparations of said compounds and their use in the manufacturing of levetiracetam and analogues |
| 10/14/2004 | US20040204475 Pharmaceutical combination |
| 10/14/2004 | US20040204474 Hypotensive agents; cardiovascular disorders |
| 10/14/2004 | US20040204473 Substituted tricyclics |
| 10/14/2004 | US20040204472 Administering to the subject a Cox-2 inhibitor for therapy and prophylaxis of obesity and obesity-related complications |
| 10/14/2004 | US20040204471 Treatment and prevention of otic disorders with Cox-2 inhibitors alone or in combination with otic agents |
| 10/14/2004 | US20040204469 Use of cox-2 inhibitors for the treatment of schizophrenia, delusional disorders, affective disorders, autism or tic disorders |
| 10/14/2004 | US20040204467 Use of 5HT3-receptor-antagonists |
| 10/14/2004 | US20040204466 Treatment of bronchial asthma using 5-HT3 receptor antagonists |
| 10/14/2004 | US20040204465 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 10/14/2004 | US20040204464 Isoxazoline compounds having MIF antagonist activity |
| 10/14/2004 | US20040204462 E.g., l2-{3-[2-(4-Fluorophenyl)oxazol-4-ylmethoxy]cyclohexyloxy}-6-methylbenzoic acid; lipid- and/or triglyceride-lowering properties; metabolic disorders; antidiabetic agents (type II); therapy of syndrome X; eating disorders; cardiomyopathy |
| 10/14/2004 | US20040204461 1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 10/14/2004 | US20040204458 Use of Lck inhibitors for treatment of immunologic diseases |
| 10/14/2004 | US20040204457 Use of (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4- piperidinemethanol or its prodrug in the treatment of symptoms of dementia and dopamine induced psychosis |
| 10/14/2004 | US20040204456 Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate |
| 10/14/2004 | US20040204453 For therapy of irritable bowel syndrome, drug addiction or dependency, including alcohol addiction, depression, anxiety, schizophrenia, anxiety, schizophrenia and eating disorders |
| 10/14/2004 | US20040204451 Prevention reproduction of virus |